Literature DB >> 11413322

Cell-type-specific regulation of the two foamy virus promoters.

C D Meiering1, C Rubio, C May, M L Linial.   

Abstract

The foamy virus (FV) genome contains two promoters, the canonical long terminal repeat (LTR) promoter, containing three consensus AP-1 binding sites, and an internal promoter (IP) within the env gene. We investigated the regulation of the two promoters in lytic and persistent infections and found that in the presence of a constitutive source of the viral transactivator protein Tas, transactivation of the LTR promoter and that of the IP differ. In lytic infections, both the LTR promoter and the IP are efficiently transactivated by Tas, while in persistent infections, the IP is efficiently transactivated by Tas, but the LTR promoter is not. Analysis of proteins expressed from the LTR promoter and the IP during infection indicated that IP transcription is more robust than that of the LTR promoter in persistently infected cells, while the opposite is true for lytically infected cells. Coculture experiments also showed that LTR promoter transcription is greatest in cells which support lytic replication. Replacement of much of the LTR promoter with the IP leads to increased viral replication in persistent but not lytic infections. We also found that the induction of persistently infected cells with phorbol 12-myristate 13-acetate (PMA) greatly enhanced viral replication and transcription from the SFVcpz(hu) (new name for human FV) LTR promoter. However, mutation of three consensus AP-1 binding sites in the FV LTR promoter did not affect viral replication in lytically or persistently infected cells, nor did the same mutations affect LTR promoter transactivation by Tas in PMA-treated cells. Our data indicate that differential regulation of transcription is important in the outcome of FV infection but is unlikely to depend on AP-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413322      PMCID: PMC114378          DOI: 10.1128/JVI.75.14.6547-6557.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures.

Authors:  W Muranyi; R M Flügel
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter.

Authors:  M Löchelt; W Muranyi; R M Flügel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

3.  Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene.

Authors:  M E Callahan; W M Switzer; A L Matthews; B D Roberts; W Heneine; T M Folks; P A Sandstrom
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

4.  Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1.

Authors:  C C Hughes; J S Pober
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

5.  Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene.

Authors:  M Löchelt; H Zentgraf; R M Flügel
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

6.  Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat.

Authors:  B Maurer; E Serfling; V ter Meulen; A Rethwilm
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Cell-specific bifunctional role of Jun oncogene family members on glucocorticoid receptor-dependent transcription.

Authors:  M Maroder; A R Farina; A Vacca; M P Felli; D Meco; I Screpanti; L Frati; A Gulino
Journal:  Mol Endocrinol       Date:  1993-04

8.  Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus.

Authors:  K J Lee; A H Lee; Y C Sung
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Transient immunosuppressive effect induced in rabbits and mice by the human spumaretrovirus prototype HFV (human foamy virus).

Authors:  M Santillana-Hayat; F Rozain; P Bittoun; C Chopin-Robert; J Lasneret; J Périès; M Canivet
Journal:  Res Virol       Date:  1993 Sep-Oct

10.  Mitogen stimulation of T-cells increases c-Fos and c-Jun protein levels, AP-1 binding and AP-1 transcriptional activity.

Authors:  A Kvanta; E Kontny; M Jondal; S Okret; B B Fredholm
Journal:  Cell Signal       Date:  1992-05       Impact factor: 4.315

View more
  21 in total

1.  Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression.

Authors:  S M Murray; L J Picker; M K Axthelm; M L Linial
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Reactivation of a complex retrovirus is controlled by a molecular switch and is inhibited by a viral protein.

Authors:  Christopher D Meiering; Maxine L Linial
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

3.  Intra- and intercellular trafficking of the foamy virus auxiliary bet protein.

Authors:  Charles-Henri Lecellier; Wim Vermeulen; Françoise Bachelerie; Marie-Lou Giron; Ali Saïb
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Mucosal and systemic antibody responses in humans infected with simian foamy virus.

Authors:  James E Cummins; Roumiana S Boneva; William M Switzer; Logan L Christensen; Paul Sandstrom; Walid Heneine; Louisa E Chapman; Charlene S Dezzutti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  N-Myc interactor inhibits prototype foamy virus by sequestering viral Tas protein in the cytoplasm.

Authors:  Xiaomei Hu; Wei Yang; Ruikang Liu; Yunqi Geng; Wentao Qiao; Juan Tan
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

6.  Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells.

Authors:  Katarzyna Kaczmarek Michaels; Malini Natarajan; Zelda Euler; Galit Alter; Gregory Viglianti; Andrew J Henderson
Journal:  J Immunol       Date:  2015-02-20       Impact factor: 5.422

7.  Persistent infection with primate foamy virus type 1 increases human immunodeficiency virus type 1 cell binding via a Bet-independent mechanism.

Authors:  Cecile Schiffer; Charles-Henri Lecellier; Abdelkrim Mannioui; Nathalie Felix; Elisabeth Nelson; Jacqueline Lehmann-Che; Marie-Louise Giron; Jean Claude Gluckman; Ali Saib; Bruno Canque
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections.

Authors:  Shannon M Murray; Louis J Picker; Michael K Axthelm; Kelly Hudkins; Charles E Alpers; Maxine L Linial
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

9.  Analysis of bovine foamy virus btas mRNA transcripts during persistent infection.

Authors:  Wei Wang; Juan Tan; Jian Wang; Qimin Chen; Yunqi Geng; Wentao Qiao
Journal:  Virus Genes       Date:  2009-11-13       Impact factor: 2.332

10.  The promyelocytic leukemia protein does not mediate foamy virus latency in vitro.

Authors:  Christopher D Meiering; Maxine L Linial
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.